Malignant hyperthermia in the emergency department. Early recognition of an impending mh crisis and prompt emergency response is critical for a. Underlying physiologic mechanism abnormal handling of intracellular calcium levels. Guidelines for the management of a malignant hyperthermia. Hyperthermia is defined by body temperature greater than bodys intrinsic regulatory set point from excessive heat production or inefficient heat dissipation. Malignant hyperthermia mh is a dangerous reaction that is triggered in response to certain anesthetic drugs. Neuromuscular malignant syndrome is a febrile idiosyncratic reaction to. Malignant hyperthermia crisis preparedness and treatment. Malignant hyperthermia mh is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane, isoflurane and the depolarizing muscle relaxant succinylcholine, and rarely, in humans, to stressors such as vigorous exercise and heat. Hyperthermia international emergency medicine education project. Extreme temperature elevation then becomes a medical emergency requiring immediate treatment to prevent disability or death. Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia susceptible individual is exposed to a volatile anesthetic such as halothane, isoflurane.
Malignant hyperthermia occurs in persons who have a genetic inherited susceptibility to this medical problem. Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermiasusceptible individual is exposed to a volatile anesthetic such as halothane, isoflurane. Guidelines for management of a malignant hyperthermia mh. Malignant hyperthermia is seen in persons who suffer from a muscle abnormality that is quite rare. However, the symptoms can be delayed for up to 12 hours. Emergent treatment of neuroleptic malignant syndrome. A policy appropriate for the facility type exists to treat and transport a patient in mh. Call 911 for transfer 24hr mhaus hotline 18006449737 x 0 malignant hyperthermia mh emergency response circulating nurse dantrolene nurse medication nurse cooling nurse. Malignant hyperthermia mh is a potentially fatal, inherited disorder usually associated with the administration of certain general anesthetics andor the drug succinylcholine. Recall nursing staff responsibilities for patient care. Neuroleptic malignant syndrome nms is a rare but potentially fatal complication of antipsychotic drug therapy. It generally due to failed thermoregulation which occurs when a body produces or absorbs more heat than it disseminates. Malignant hyperthermia is diagnosed on clinical grounds, but various laboratory investigations may prove confirmatory.
Emergent treatment of neuroleptic malignant syndrome induced. Which statement by a student indicates a need for further teaching. To give the patient the best possible chance for a successful outcome, a swift, coordinated, multidisciplinary team response is necessary. We report the case of an 8yearold child who underwent surgery for an eyeball burst and had a very severe malignant hyperthermia attack. Additionally, ast recognizes that the anesthesia provider and surgeon direct the care of the patient during an acute mh episode. Tachycardia, mixed respiratory and metabolic acidosis are present due to the hypermetabolic state. Recognizing and managing a malignanthyperthermia crisis. Emergency therapy for malignant hyperthermia poster. Jan 30, 2020 malignant hyperthermia is a disorder which triggers high fever, an increased heartbeat, rigidity in muscles and disintegration of muscle fibers when individuals prone to it are exposed to certain drugs used in surgical procedures. Actively cool patient with ice packs, lavage if open abdomen. Malignant hyperthermia association of the united states.
The signs of mh include a greatly increased body metabolism, muscle rigidity and eventual. Emergency therapy for mh protocol poster revision date mhaus. Malignant hyperthermia diagnosis and treatment medical. Ryanodex is not a substitute for appropriate supportive measures in the treatment of malignant hyperthermia mh, including discontinuing use of mhtriggering anesthetic agents, managing the metabolic acidosis, instituting cooling when necessary, and administering diuretics to prevent late kidney injury due to myoglobinuria the amount of mannitol in ryanodex. Introduction malignant hyperthermia mh manifests clinically as a hypermetabolic crisis when an mhsusceptible mhs individual is exposed to a volatile anesthetic eg, halothane, isoflurane, sevoflurane, desflurane or succinylcholine this topic will discuss the incidence, pathophysiology, clinical manifestations, and acute management of mh. Maysel ann hetrick, bsn, cen, emtb, mobile, alabama a 35yearold man was brought to the emergency department by his family with nonspecific symptoms of abdominal discomfort, headache, and sore throat for 1 week. Follow standard icu therapy for acute rhabdomyolysis ad myoglobinuria. Hyperventilate with 100% oxygen at flows of 10 lmin. Immediate action with initial suspicion of malignant hyperthermia includes removing the substance of abuse, terminating surgery as soon as possible, and, if necessary, changing to safer anesthetics see above. A prospective physician should be familiar with these emergencies. Malignant hyperthemia and related disorders hotline available 247. Malignant hyperthermia association of the united states mhaus and are viewed as the standard of care for treating the patient in surgery. How can you tell if you have malignant hyperthermia.
Symptoms of malignant hyperthermia usually occur within the first hour after exposure to the trigger medication. Review gmha guidelines for the care of mh patients. However, the cst serves as another pair of eyes in the or and should be. Emergency medicine malignant hyperthermia diagnosis and treatment see online here while anesthesia has become safer and safer in past years, there are some rare but dreaded complications, which can rapidly worsen the state of the patients and can even lead to their death. Mhanz the author of this resource kit is a group of experts who are involved in malignant hyperthermia testing and research. The muscle abnormality that can lead to malignant hyperthermia is caused by one of several genetic mutations. An inherited disorder, malignant hyperthermia mh is a life threatening reaction. Malignant hyperthermia in the emergency department authors. Hyperthermia international emergency medicine education. Emergency treatment for an acute mh event the following four.
Approved october 2005 revised april 9, 2018 guidelines for. Most cases occur in children and adults younger than 30. Malignant hyperthermia is a rare but very serious complication with high mortality and the treatment is based on the early administration of dantrolene sodium. Clinical presentation glahn kp, ellis fr, halsall pj, muller cr, snoeck mm, urwyler a, wappler f. Malignant hyperthermia mh is a disease that causes a fast rise in body temperature and severe muscle contractions when someone with mh gets general anesthesia. Malignant hyperthermia is a potentially lethal inherited disorder characterized by disturbance of calcium homeostasis in skeletal muscle.
Alternatively, contact prof p hopkins, dr e watkins or dr p gupta through hospital switchboard. Malignant hyperthermia, 27042009 page 4 of 6 treatment of malignant hyperthermia early diagnosis and treatment are key to successful management on recognition of a reaction several modes of treatment need to be started at once. Emergency therapy of malignant hyperthermia immediate action with initial suspicion of malignant hyperthermia includes removing the substance of abuse, terminating surgery as soon as possible, and, if necessary, changing to safer anesthetics see above. Mh reactions are potentially fatal if prompt appropriate treatment is not instituted. Malignant hyperthermia association of the united states 7. Malignant hyperthermia mh is a rare, inherited musculoskeletal syndrome that presents as a hypermetabolic reaction triggered by exposure to volatile anesthetic gases e. Produced by the malignant hyperthermia association of the united states. Increasing endtidal co 2 is usually the first sign of mh. Malignant hyperthermia mh is a rare, inherited skeletal muscle syndrome that presents as a. Malignant hyperthermia mh is a type of severe reaction that occurs in response to particular medications used during general anesthesia, among those who are susceptible. Blurb from the malignant hyperthermia association of the united states mhaus regarding the 20182019 emergency therapy for mh protocol poster revision dates.
Therapy includes immediate cooling, support of failing organ systems, and repletion of fluids. Visual aid to guide dantrolene sodium preparation from hirshey dirksen sj, van wicklin sa, mashman dl, neiderer p, merritt dr. Malignant hyperthermia mh is a rare, inherited skeletal muscle syndrome. Malignant hyperthermia characteristics an inherited disorder of skeletal muscle triggered in most instances by inhalation agents andor succinylcholine, resulting in hypermetabolism, skeletal muscle damage, hyperthermia, and death if untreated. In case of emergency, contact the 24hour mhaus hotline at 800. Malignant hyperthermia mh is a rare disorder of skeletal muscles related to. Developing effective drills in preparation for a malignant hyperthermia drill. Malignant hyperthermia anesthesiology jama jama network. Family history of death during general anesthesia being put to sleep for surgery or having a high body temperature during or after general. This condition is not the same as hyperthermia from medical emergencies such as heat stroke or infection. See more ideas about malignant hyperthermia, operating room nurse and nursing exam. These include a raised creatine kinase level, elevated potassium, increased phosphate leading to decreased calcium andif determinedraised myoglobin. This is not the same as fever, which involves elevation in bodys internal set point.
If available insert activated charcoal filters into the inspiratory and expiratory limbs of. Guidelines for management of a malignant hyperthermia mh crisis an evolving mh reaction and exclusion of other differential causes. Successful management of malignant hyperthermia depends upon early diagnosis and treatment. Malignant hyperthermia is a disorder inherited by individuals which when exposed to a skeletal muscle relaxant named succinylcholine used during intubation or surgery, and general anesthesia via inhalation experience a severe possibly fatal reaction leading to hypermetabolism. Malignant hyperthermia continued from previous page treatment 7. Successful treatment of a malignant hyperthermia mh crisis depends on early diagnosis and aggressive treatment. Malignant hyperthermia mh is a rare pharmacogenetic disorder.
Symptoms include muscle rigidity, high fever, and a fast heart rate. Mh susceptible patient emergency care checklist mhaus. This is a genetically inherited condition and runs in the family. Malignant hyperthermia crisis preparedness and treatment aana. Malignant hyperthermia mh is severe, potentially fatal increased body energy consumption after exposure to certain anesthetic drugs. Patients with agitation and hyperthermia present several challenges for emergency clinicians. Tautz malignant hyperthermia mh, an eerie and erratic metabolic mayhem, is a clinical syndrome that in its classic form occurs during anesthesia with a potent volatile agent such. Dantrolene helps to slow the metabolic activity in skeletal muscles. Most people who are susceptible are generally otherwise normal when not exposed. It is important to know where the dantrolene is kept in your theatre. Analgesics should be given to help with muscle pain. No authors listed malignant hyperthermia mh is a hypermetabolic syndrome triggered in genetically susceptible individuals when certain potent inhalation anesthetics or succinylcholine are administered. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006. If limb muscle rigidity, begin treatment with dantrolene.
691 1408 40 165 395 523 384 1518 1251 514 344 37 1033 502 672 445 1461 686 735 1306 1324 1491 484 1051 1340 1553 212 855 1462 505 1208 45 433 901 635 1051 1223 1088 760 171 535 154 1127